Abstract
The new mixed dopamaine D2/serotonin 5-HT2A antagonist, Fanapt (iloperidone), was approved by the FDA on May 6th, 2009 for the treatment of schizophrenia in adults.
Original language | English (US) |
---|---|
Pages (from-to) | 410 |
Number of pages | 1 |
Journal | ACS Chemical Neuroscience |
Volume | 1 |
Issue number | 6 |
DOIs | |
State | Published - Jun 16 2010 |
Externally published | Yes |
ASJC Scopus subject areas
- Biochemistry
- Physiology
- Cognitive Neuroscience
- Cell Biology